BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38267509)

  • 1. Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling.
    Dang C; Bian Q; Wang F; Wang H; Liang Z
    Sci Rep; 2024 Jan; 14(1):2116. PubMed ID: 38267509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
    J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.
    Sikder MOF; Sivaprakasam S; Brown TP; Thangaraju M; Bhutia YD; Ganapathy V
    Biochem J; 2020 Apr; 477(8):1409-1425. PubMed ID: 32219372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer.
    Zhou P; Li Y; Li B; Zhang M; Liu Y; Yao Y; Li D
    Oncogene; 2019 Jul; 38(27):5500-5515. PubMed ID: 30967633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling.
    Li TH; Zhao BB; Qin C; Wang YY; Li ZR; Cao HT; Yang XY; Zhou XT; Wang WB
    Cell Oncol (Dordr); 2021 Dec; 44(6):1425-1437. PubMed ID: 34791638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration.
    Han GD; Dai J; Hui HX; Zhu J
    J Orthop Surg Res; 2023 Jun; 18(1):446. PubMed ID: 37344882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZNF281 Promotes Growth and Invasion of Pancreatic Cancer Cells by Activating Wnt/β-Catenin Signaling.
    Qian Y; Li J; Xia S
    Dig Dis Sci; 2017 Aug; 62(8):2011-2020. PubMed ID: 28523575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway.
    Li Z; Huang X; Hu W; Lu H
    Tissue Cell; 2022 Aug; 77():101787. PubMed ID: 35623308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer.
    Li Z; Ma Z; Zhou Q; Wang S; Yan Q; Zhuang H; Zhou Z; Liu C; Wu Z; Zhao J; Huang S; Zhang C; Hou B
    Heliyon; 2022 Nov; 8(11):e11321. PubMed ID: 36406681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β.
    Chen LJ; Wu L; Wang W; Zhai LL; Xiang F; Li WB; Tang ZG
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 35929518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.
    Peng Y; Zhang X; Lin H; Deng S; Qin Y; Yuan Y; Feng X; Wang J; Chen W; Hu F; Yan R; Zhao Y; Cheng Y; Wei Y; Fan X; Ashktorab H; Smoot D; Li S; Meltzer SJ; Jin Z
    Cell Cycle; 2020 Oct; 19(20):2720-2733. PubMed ID: 33017570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PITX2 in pancreatic stellate cells promotes EMT in pancreatic cancer cells via the Wnt/β-catenin pathway.
    Wu D; Chen W; Yang Y; Qin Y; Zu G; Zhang Y; An Y; Sun D; Xu X; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(9):1393-1403. PubMed ID: 37337632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway.
    Cai K; Deng L; Zheng D; Li L; He Z; Yu C
    J Transl Med; 2022 Nov; 20(1):528. PubMed ID: 36371204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway.
    Li F; Dai L; Niu J
    J Cell Physiol; 2020 Nov; 235(11):7780-7790. PubMed ID: 31774184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STMN2 overexpression promotes cell proliferation and EMT in pancreatic cancer mediated by WNT/β-catenin signaling.
    Shao M; Wang L; Zhang Q; Wang T; Wang S
    Cancer Gene Ther; 2023 Mar; 30(3):472-480. PubMed ID: 36460804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis
    Peng X; Yang R; Song J; Wang X; Dong W
    Front Med (Lausanne); 2022; 9():783592. PubMed ID: 35707527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.